Immunogen, Inc. (IMGN) Posts Q2 Loss of 29c/Share; Revs Light

Immunogen, Inc. (NASDAQ: IMGN) reported Q2 EPS of ($0.29), $0.04 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $2.6 million versus the consensus estimate of $6.02 million.

For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Phreesia Inc. (PHR) Misses Q2 EPS by 6c; Offers Guidance
• Netskope, Inc. (NTSK) Tops Q2 EPS by 4c, Offers Guidance